Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glioblastoma Tumors and GBOs

ABSTRACT: Glioblastoma Tumors and GBOs

PROVIDER: PRJNA595363 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10677900_1.fastq.gz	Fastqsanger.gz
	SRR10677900_2.fastq.gz	Fastqsanger.gz
	SRR10677901_1.fastq.gz	Fastqsanger.gz
	SRR10677901_2.fastq.gz	Fastqsanger.gz
	SRR10677802_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 268

Similar Datasets

Expression data from glioblastoma derived xenograft and original glioblastoma tumors

Project description:Expression data from glioblastoma derived xenograft and original glioblastoma tumors

| PRJNA1172693 | ENA

RNA-seq of Glioblastoma Tumors and GBOs

Project description:RNA-seq of Glioblastoma Tumors and GBOs

| PRJNA595365 | ENA

Exome-seq of Glioblastoma Tumors and GBOs

Project description:Exome-seq of Glioblastoma Tumors and GBOs

| PRJNA595366 | ENA

Transcription profiling of human glioblastoma multiforme tumors taken before dendritic cell vaccination, recurrent tumors after vaccination and control GBM tumors

Project description:Human Glioblastoma Multiforme tumors taken before dendritic cell vaccination, the recurrent tumors taken after vaccination and control GBM tumors from non vaccinated patients. Experiment Overall Design: Six Glioblastoma Multiforme patients underwent surgery. Their brain tumors were removed and analyzed via microarray. The lysate from the tumors were cultured with the patients' dendritic cells and the DCs were injected back into the patients. The patients GBMs returned and they underwent surgery a second time and those tumors were also analyzed via microarray. Tumors from the first and second GBM surgeries of 5 patients who did not receive DC vaccines are included as controls.

2009-04-11 | E-GEOD-11100 | biostudies-arrayexpress

Expression data from glioblastoma derived xenograft and original glioblastoma tumors

Project description:Amplification of the epidermal growth factor receptor (EGFR, A0 for non-amplified and A1 for amplified) gene is one of the most common oncogenic alterations in glioblastoma (45%) making it a prime target for therapy. However, small molecule inhibitors of the EGFR tyrosine kinase showed disappointing efficacy in clinical trials for glioblastoma. Here we report expression data for 33 samples including 6 GBM derived xenografts (3 controls and 3 treated by tyrosine kinase inhibitor gefitinib) and 27 glioblastoma tumors (11 controls and 16 treated by tyrosine kinase inhibitor gefitinib). Note that T0, T1 and T2 treatment types mean that control, Gefitinib treatment and Gefitinib treatment (but not according to protocol schedule), respectively.

2024-10-21 | GSE279426 | GEO

Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

Project description:Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

| PRJNA478619 | ENA

RNA Sequencing of adult high grade glioblastoma tumors

Project description:RNA Sequencing of adult high grade glioblastoma tumors

| PRJNA451200 | ENA

Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

Project description:Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

| PRJNA478618 | ENA

Transcription profiling of human grade II astrocytic tumor (astrocytomas) vs grade IV tumors (glioblastoma)

Project description:Comparison of grade II astrocytic tumor (astrocytomas) with grade IV tumors (glioblastoma)